Testing a glucose-monitoring device in septic shock ICU
Part of Heart & circulation, Hormones & metabolism, Infections clinical trials.
This trial checks whether a continuous glucose monitoring system (“CGM GUARDIAN 2”) can be used safely and effectively for people in the ICU who have septic shock and high blood sugar. It may help the medical team track blood sugar more easily while you receive insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the ICU with septic shock (a serious infection affecting the whole body).
- Your blood pressure is low and you need noradrenaline to keep it up.
- Your blood sugar is high enough that you are being treated with insulin.
- You are not pregnant and not breastfeeding.
- You are able to consent (not under legal protection such as guardianship/curatorship, and not deprived of liberty).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This study tests a new way to monitor blood sugar in the intensive care unit (ICU) using a small sensor that sends readings wirelessly to the care team. If you have high blood sugar and are on insulin, this could help keep your levels more stable without frequent finger pricks.
This trial tests if using a continuous glucose monitor (CGM) after leaving the hospital helps manage diabetes. You wear a small sensor on your arm that checks your sugar levels all day and sends them to your phone.
This study tests a continuous glucose monitor (CGM), a small sensor that tracks your blood sugar, in people who had a stroke and also have diabetes or high blood sugar. The goal is to see how well the sensor works and if it helps manage blood sugar during recovery.
This trial tests a continuous glucose monitoring system (Syai Tag) in the intensive care unit (ICU). It aims to see how well it measures blood sugar levels safely compared to standard methods.
This trial tests a continuous glucose monitoring system for people in the intensive care unit (ICU). It checks how well the device measures blood sugar and if it can help predict outcomes for critically ill patients.
Hear when a new Hyperglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.